Suppression of Protein Phosphatase 2 Differentially Modulates VEGF- and FGF2-Induced Signaling in Ovine Fetoplacental Artery Endothelial Cells

Placenta

Volumn 30, Issue 10, 2009, Pages 907-913

  Song, Y ^a   Wang, K ^a   Chen, D b ^b   Magness, R R ^a,c   Zheng, J ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Endothelial cell; Placenta; Signaling transduction

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; FIBROBLAST GROWTH FACTOR 2; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 2; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOPROTEIN PHOSPHATASE 2; PHOSPHOPROTEIN PHOSPHATASE 2A; SMALL INTERFERING RNA; VASCULOTROPIN;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME SUBUNIT; FETOPLACENTAL UNIT; IMMUNOPRECIPITATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PLACENTA CIRCULATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANIMALS; ARTERIES; CATALYSIS; CELL PROLIFERATION; CELLS, CULTURED; ENDOTHELIAL CELLS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; FIBROBLAST GROWTH FACTOR 2; NITRIC OXIDE SYNTHASE TYPE III; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PLACENTA; PREGNANCY; PROTEIN ISOFORMS; PROTEIN PHOSPHATASE 2; PROTO-ONCOGENE PROTEINS C-AKT; RNA, SMALL INTERFERING; SHEEP; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 70149108272     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.placenta.2009.07.003     Document Type: Article

References (45)

1. Alexander G. Birth weight of lambs: influences and consequences. In: Elliott K., and Knight J. (Eds). Ciba foundation symposium 27: size at birth (1974), Elsevier, New York 215-245
2. Rosenfeld C.R., Morriss Jr. F.H., Makowski E.L., Meschia G., and Battaglia F.C. Circulatory changes in the reproductive tissues of ewes during pregnancy. Gynecol Invest 5 (1974) 252-268
3. Reynolds L.P., and Redmer D.A. Utero-placental vascular development and placental function. J Anim Sci 73 (1995) 1839-1851
4. Barcroft J., and Barron D.H. Observations upon the form and relations of the maternal and fetal vessels in the placenta of the sheep. Anat Rec 94 (1946) 569-595
5. Magness R.R., and Zheng J. Circulatory changes during gestation. In: Gluckman P.D., and Heymann M.A. (Eds). Scientific basis of pediatric and perinatal medicine. 2nd edition. (1996), Edward Arnold Publishers, London 762-772
6. Ferrara N., Houck K., Jakeman L., and Leung D.W. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev 13 (1992) 18-32
7. Klagsbrun M., and D'Amore P.A. Regulators of angiogenesis. Annu Rev Physiol 53 (1991) 217-239
8. Bogic L.V., Brace R.A., and Cheung C.Y. Developmental expression of vascular endothelial growth factor (VEGF) receptors and VEGF binding in ovine placenta and fetal membranes. Placenta 22 (2001) 265-275
9. Ferrara N., Gerber H.P., and LeCouter J. The biology of VEGF and its receptors. Nat Med 9 (2003) 669-676
10. Powers C.J., McLeskey S.W., and Wellstein A. Fibroblast growth factors, their receptors and signaling. Endocr Relat Cancer 7 (2000) 165-197
11. Reynolds L.P., Borowicz P.P., Vonnahme K.A., Johnson M.L., Grazul-Bilska A.T., Wallace J.M., et al. Animal models of placental angiogenesis. Placenta 26 (2005) 689-708
12. Sladek S.M., Magness R.R., and Conrad K.P. Nitric oxide and pregnancy. Am J Physiol 272 (1997) R441-R463
13. Boilly B., Vercoutter-Edouart A.S., Hondermarck H., Nurcombe V., and Le Bourhis X. FGF signals for cell proliferation and migration through different pathways. Cytokine Growth Factor Rev 11 (2000) 295-302
14. Cantley L.C. The phosphoinositide 3-kinase pathway. Science 296 (2002) 1655-1657
15. Matsumoto T., and Claesson-Welsh L. VEGF receptor signal transduction. Sci STKE 2001 (2001) RE21
16. Zarubin T., and Han J. Activation and signaling of the p38 MAP kinase pathway. Cell Res 15 (2005) 11-18
17. Ono K., and Han J. The p38 signal transduction pathway activation and function. Cell Signal 12 (2000) 1-13
18. Zheng J., Bird I.M., Melsaether A.N., and Magness R.R. Activation of the mitogen-activated protein kinase cascade is necessary but not sufficient for basic fibroblast growth factor- and epidermal growth factor-stimulated expression of endothelial nitric oxide synthase in ovine fetoplacental artery endothelial cells. Endocrinology 140 (1999) 1399-1407
19. Barford D., Das A.K., and Egloff M.P. The structure and mechanism of protein phosphatases: insights into catalysis and regulation. Annu Rev Biophys Biomol Struct 27 (1998) 133-164
20. Camps M., Nichols A., and Arkinstall S. Dual specificity phosphatases: a gene family for control of MAP kinase function. FASEB J 14 (2000) 6-16
21. Cohen P., and Cohen P.T. Protein phosphatases come of age. J Biol Chem 264 (1989) 21435-21438
22. Lechward K., Awotunde O.S., Swiatek W., and Muszynska G. Protein phosphatase 2A: variety of forms and diversity of functions. Acta Biochim Pol 48 (2001) 921-933
23. Mumby M.C., and Walter G. Protein serine/threonine phosphatases: structure, regulation, and functions in cell growth. Physiol Rev 73 (1993) 673-699
24. Sontag E. Protein phosphatase 2A: the Trojan Horse of cellular signaling. Cell Signal 13 (2001) 7-16
25. Gotz J., Probst A., Ehler E., Hemmings B., and Kues W. Delayed embryonic lethality in mice lacking protein phosphatase 2A catalytic subunit Calpha. Proc Natl Acad Sci U S A 95 (1998) 12370-12375
26. Alessi D.R., Gomez N., Moorhead G., Lewis T., Keyse S.M., and Cohen P. Inactivation of p42 MAP kinase by protein phosphatase 2A and a protein tyrosine phosphatase, but not CL100, in various cell lines. Curr Biol 5 (1995) 283-295
27. Janssens V., and Goris J. Protein phosphatase 2A: a highly regulated family of serine/threonine phosphatases implicated in cell growth and signalling. Biochem J 353 (2001) 417-439
28. Silverstein A.M., Barrow C.A., Davis A.J., and Mumby M.C. Actions of PP2A on the MAP kinase pathway and apoptosis are mediated by distinct regulatory subunits. Proc Natl Acad Sci U S A 99 (2002) 4221-4226
29. Van Kanegan M.J., Adams D.G., Wadzinski B.E., and Strack S. Distinct protein phosphatase 2A heterotrimers modulate growth factor signaling to extracellular signal-regulated kinases and Akt. J Biol Chem 280 (2005) 36029-36036
30. Liao Y., and Hung M.C. A new role of protein phosphatase 2a in adenoviral E1A protein-mediated sensitization to anticancer drug-induced apoptosis in human breast cancer cells. Cancer Res 64 (2004) 5938-5942
31. Lee T., Kim S.J., and Sumpio B.E. Role of PP2A in the regulation of p38 MAPK activation in bovine aortic endothelial cells exposed to cyclic strain. J Cell Physiol 194 (2003) 349-355
32. Gabel S., Benefield J., Meisinger J., Petruzzelli G.J., and Young M. Protein phosphatases 1 and 2A maintain endothelial cells in a resting state, limiting the motility that is needed for the morphogenic process of angiogenesis. Otolaryngol Head Neck Surg 121 (1999) 463-468
33. Young M.R., Kolesiak K., and Meisinger J. Protein phosphatase-2A regulates endothelial cell motility and both the phosphorylation and the stability of focal adhesion complexes. Int J Cancer 100 (2002) 276-282
34. Knapp J., Boknik P., Luss I., Huke S., Linck B., Luss H., et al. The protein phosphatase inhibitor cantharidin alters vascular endothelial cell permeability. J Pharmacol Exp Ther 289 (1999) 1480-1486
35. Murata K., Mills I., and Sumpio B.E. Protein phosphatase 2A in stretch-induced endothelial cell proliferation. J Cell Biochem 63 (1996) 311-319
36. Song Y., and Zheng J. Establishment of a functional ovine fetoplacental artery endothelial cell line with a prolonged life span. Biol Reprod 76 (2007) 29-35
37. Zheng J., Wen Y., Song Y., Wang K., Chen D.B., and Magness R.R. Activation of multiple signaling pathways is critical for fibroblast growth factor 2- and vascular endothelial growth factor-stimulated ovine fetoplacental endothelial cell proliferation. Biol Reprod 78 (2008) 143-150
38. Liao W.X., Feng L., Zhang H.H., Zheng J., Moore T.R., and Chen D.B. Compartmentalizing VEGF-induced ERK2/1 signaling in placental artery endothelial cell caveolae: a paradoxical role of caveolin-1 in placental angiogenesis in vitro. Mol Endocrinol (2009; May 28) [Epub ahead of print]
39. Wang K., Song Y., Chen D.B., and Zheng J. Protein phosphatase 3 differentially modulates vascular endothelial growth factor- and fibroblast growth factor 2-stimulated cell proliferation and signaling in ovine fetoplacental artery endothelial cells. Biol Reprod 79 (2008) 704-710
40. Zheng J., Bird I.M., Chen D.B., and Magness R.R. Angiotensin II regulation of ovine fetoplacental artery endothelial functions: interactions with nitric oxide. J Physiol 565 (2005) 59-69
41. Rafiee P., Heidemann J., Ogawa H., Johnson N.A., Fisher P.J., Li M.S., et al. Cyclosporin A differentially inhibits multiple steps in VEGF induced angiogenesis in human microvascular endothelial cells through altered intracellular signaling. Cell Commun Signal 2 (2004) 3
42. McCright B., Rivers A.M., Audlin S., and Virshup D.M. The B56 family of protein phosphatase 2A (PP2A) regulatory subunits encodes differentiation-induced phosphoproteins that target PP2A to both nucleus and cytoplasm. J Biol Chem 271 (1996) 22081-22089
43. Xu Z., and Williams B.R. The B56alpha regulatory subunit of protein phosphatase 2A is a target for regulation by double-stranded RNA-dependent protein kinase PKR. Mol Cell Biol 20 (2000) 5285-5299
44. Mata-Greenwood E., Liao W.X., Zheng J., and Chen D.B. Differential activation of multiple signalling pathways dictates eNOS upregulation by FGF2 but not VEGF in placental artery endothelial cells. Placenta 29 (2008) 708-717
45. Fernandez J.J., Candenas M.L., Souto M.L., Trujillo M.M., and Norte M. Okadaic acid, useful tool for studying cellular processes. Curr Med Chem 9 (2002) 229-262